Awards Dr. Lisa Tachiki Named Kuni Foundation 2025 Cancer Research Fellow Fred Hutch | March 25, 2026 Fred Hutch Cancer Center medical oncologist Lisa Tachiki, MD, has been named a 2025 Cancer…karnottMarch 25, 2026 Read More
Publications of the Week Divergent Effects of a Treg-Selective IL-2 Mutein on Influenza-Specific T Cell Responses Albe, J., et al. | March 25, 2026 Enhancing regulatory T cell (Treg) function offers a compelling therapeutic strategy for autoimmune disease. Engineered…karnottMarch 25, 2026 Read More
Local News Mind Trip: How Psilocybin Changes the Brain Allen Institute | March 24, 2026 “The rewiring in the mouse brain from psilocybin is not haphazard; there’s a definite pattern…karnottMarch 24, 2026 Read More
Local News Fred Hutch Collaboration Reveals Molecular Vulnerability in Rare Childhood Brain Cancer Allen Institute | March 24, 2026 When broken strands of DNA get repaired improperly, they can stitch together in new “Frankengene”…karnottMarch 24, 2026 Read More
Publications of the Week Dynamics of Phage-Host Interactions in Bacteroides fragilis Resolved by Single-Cell Transcriptomics Gupta, A., et al. | March 23, 2026 The interactions between lytic phages and their hosts are typically studied in bulk culture, which…karnottMarch 23, 2026 Read More
Local News Giving CAR T Cells a Portable Pit Crew Fred Hutch | March 23, 2026 Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared…karnottMarch 23, 2026 Read More
Awards Washington Research Foundation Awards $250,000 to Seattle Children’s Researchers Developing Next-Generation Brain Tumor Therapy Washington Research Foundation | March 23, 2026 Washington Research Foundation (WRF) has awarded $250,000 to Jim Olson, M.D., Ph.D., and Andrew (Drew)…karnottMarch 23, 2026 Read More
Local News The Lifesaving Power of Early Colon Cancer Screening | March 20, 2026 Colorectal cancer — which affects the colon or rectum in the digestive tract — is…karnottMarch 20, 2026 Read More
Local News CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab CytoDyn | March 20, 2026 CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a…karnottMarch 20, 2026 Read More
Local News LSW Institute is Now LSW Entrepreneurship & Venture Services Life Science Washington | March 19, 2026 To better serve a broader range of entrepreneurs and companies, LSW Institute is now LSW…karnottMarch 19, 2026 Read More